Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-16-000103
Filing Date
2016-11-15
Accepted
2016-11-15 19:01:26
Documents
1
Period of Report
2016-11-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6538
  Complete submission text file 0000711377-16-000103.txt   7740
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
YEUTTER CLAYTON K (Reporting) CIK: 0001172569 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 162001027